Table 1.
Demographics and clinical measurements by group
|
Condition
|
DVH
|
HC
|
t
|
P
valuea
|
| Male/female | 16/15 | 16/15 | N/A | > 0.99 |
| Age (yr) | 56.03 ± 4.61 | 56.48 ± 4.29 | 0.041 | 0.967 |
| Weight (kg) | 60.48 ± 3.83 | 61.10 ± 3.49 | 0.118 | 0.906 |
| Handedness | 31 R | 31 R | N/A | > 0.99 |
| Duration of DVH (d) | 24.15 ± 20.97 | N/A | N/A | N/A |
| Best-corrected VA-right eye | 0.64 ± 0.05 | 1.07 ± 0.03 | -7.771 | < 0.001 |
| Best-corrected VA-left eye | 0.66 ± 0.06 | 1.06 ± 0.02 | -6.231 | < 0.001 |
| Duration of DM (yr) | 27.23 ± 19.89 | 25.85 ± 18.28 | 0.085 | 0.915 |
| HgbA1c (%) | 5.3 ± 0.4 | 4.8 ± 0.5 | 0.051 | > 0.99 |
a
P < 0.05, independent t-tests. Data shown are the mean ± SD. DVH: Diabetic vitreous hemorrhage; HC: Healthy control; N/A: Not applicable; R: Right; VA: Visual acuity; DM: Diabetes mellitus.